Produkty 82003-90-5

CAS 82003-90-5 występuje w naszej ofercie pod nazwami: Daurichromenic acid, Daurichromenic acid. Oferty producentów: GLPBio, Biosynth, MedChemExpress. Dostępne opakowania: 5mg, 2mg, 10mg, Get quote.

Daurichromenic acid
GLPBio
  • opakowanie: 5mg
  • Warianty: 1
od 6494,47
Zobacz produkt
Daurichromenic acid
Biosynth, MedChemExpress
  • opakowanie: 5mg, 2mg, 10mg, Get quote
  • Warianty: 4
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2S)-2-[(3E)-4,8-dimethylnona-3,7-dienyl]-5-hydroxy-2,7-dimethylchromene-6-carboxylic acid (CAS 82003-90-5) to związek chemiczny o wzorze sumarycznym C23H30O4 i masie molowej 370.5 g/mol. Nazwa systematyczna IUPAC: (2S)-2-[(3E)-4,8-dimethylnona-3,7-dienyl]-5-hydroxy-2,7-dimethylchromene-6-carboxylic acid. InChIKey: UYLFTJMQPWWDCW-MVLVPLOLSA-N.

Dane identyfikacyjne
Wzór sumarycznyC23H30O4
Masa molowa370.5 g/mol
Nazwa IUPAC(2S)-2-[(3E)-4,8-dimethylnona-3,7-dienyl]-5-hydroxy-2,7-dimethylchromene-6-carboxylic acid
InChIKeyUYLFTJMQPWWDCW-MVLVPLOLSA-N
SMILESCC1=CC2=C(C=C[C@](O2)(C)CC/C=C(\C)/CCC=C(C)C)C(=C1C(=O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Daurichromenic acid, (+)-Daurichromenic acid, daurichiromenic acid, (+)-Daurichromenic acid; Dauichromenic acid, orb1682832
Izomery (ten sam wzór sumaryczny)
[2-oxo-3-(2,4,6-trimethylphenyl)-1-oxaspiro[4.4]non-3-en-4-yl] 3,3-dimethylbutanoate C23H30O4
[(8R,9S,10R,13S,14S,17R)-17-acetyl-13-methyl-16-methylidene-3-oxo-2,6,7,8,9,10,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C23H30O4
[(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] acetate C23H30O4
[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6-oxo-8,9,11,12,14,15,16,17-octahydro-7H-cyclopenta[a]phenanthren-17-yl] pentanoate C23H30O4
[(8S,9S,10R,13S,14S,17R)-17-acetyl-6,13-dimethyl-3-oxo-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate C23H30O4
[(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate C23H30O4
[(3S,8R,9S,10R,13S,14S)-17-acetyl-10,13-dimethyl-7-oxo-1,2,3,4,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthren-3-yl] acetate C23H30O4
[(8R,9S,10R,13S,14S,15S,17R)-13-ethyl-17-ethynyl-17-hydroxy-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-15-yl] acetate C23H30O4
[(3R,8R,9S,10R,13S)-17-acetyloxy-10,13-dimethyl-2,3,4,7,8,9,11,12-octahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate C23H30O4
(1'R,5'S,6'S,9'S,10'S,13'R)-5'-methyl-6'-prop-1-ynylspiro[1,3-dioxolane-2,15'-18-oxapentacyclo[11.4.1.01,13.02,10.05,9]octadec-2-ene]-6'-ol C23H30O4
[2-oxo-3-(2,4,6-trimethylphenyl)-1-oxaspiro[4.4]non-3-en-4-yl] 4,4,4-trideuterio-3,3-bis(trideuteriomethyl)butanoate C23H30O4
[3-acetyloxy-2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-propylphenyl] acetate C23H30O4